Our result revealed that LAPTM4B was associated with CD8+ T cells, macrophages M2 and Tregs in many cancers, which suggested that high LAPTM4B expression had inhibitory immune microenvironment (Figures 4B, C). The gene discussed is LAPTM4B; the disease is cancer.